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Abstract 
Background: Thermophilic Campylobacter species are a major cause of bacterial foodborne diarrhoea in humans 
worldwide. Poultry and their products are the predominant source for human campylobacteriosis. Resistance of 
Campylobacter to antibiotics is increasing worldwide, but little is known about the antibiotic resistance in Campy-
lobacter isolated from chicken in Kenya. In this study, 35 suspected Campylobacter strains isolated from faeces and 
cloacal swabs of chicken were tested for their susceptibility to seven antibiotics using a broth microdilution assay and 
molecular biological investigations.
Results: Overall, DNA of thermophilic Campylobacter was identified in 53 samples by PCR (34 C. jejuni, 18 C. coli and 
one mix of both species) but only 35 Campylobacter isolates (31 C. jejuni and 4 C. coli) could be re‑cultivated after 
transportation to Germany. Isolates were tested for their susceptibility to antibiotics using a broth microdilution assay. 
Additionally, molecular biological detection of antibiotic resistance genes was carried out. C. jejuni isolates showed a 
high rate of resistance to nalidixic acid, tetracycline and ciprofloxacin of 77.4, 71.0 and 71.0 %, respectively. Low resist‑
ance (25.8 %) was detected for gentamicin and chloramphenicol. Multidrug resistance in C. jejuni could be detected 
in 19 (61.3 %) isolates. Resistance pattern of C. coli isolates was comparable. Resistance to ciprofloxacin was confirmed 
by MAMA–PCR and PCR–RFLP in all phenotypically resistant isolates. The tet(O) gene was detected only in 54.5 % of 
tetracycline resistant C. jejuni isolates. The tet(A) gene, which is also responsible for tetracycline resistance, was found 
in 90.3 % of C. jejuni and in all C. coli isolates. Thirteen phenotypically erythromycin‑resistant isolates could not be char‑
acterised by using PCR–RFLP and MAMA–PCR.
Conclusions: To the best of our knowledge, this study is the first report about resistance to antibiotics in thermo‑
philic Campylobacter originating from chicken in Kenya. Campylobacter spp. show a high level of resistance to cipro‑
floxacin, nalidixic acid and tetracycline but also a remarkable one to chloramphenicol and gentamicin and they are 
multidrug resistant. Resistance to antibiotics is a global public health concern. In Kenya, resistance surveillance needs 
further attention in the future. Efforts to establish at least a National Laboratory with facilities for performing pheno‑
typic and genotypic characterization of thermophilic Campylobacter is highly recommended.
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Background
Thermophilic Campylobacter (C.) species have become 
the most frequent cause of bacterial gastroenteritis in 
humans worldwide [1]. Campylobacteriosis exceed the 
total number of those caused by Salmonella, Shigella, 
and Escherichia coli O157:H7 in humans, recently [2]. 
Campylobacter infections are normally self-limiting in 
adults but can cause diarrhoea or even mortality in chil-
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A study from western Kenya showed that 20  % of 
patients with diarrhoea were infected by Campylobacter 
but in the group of children below 5 years Campylobacter 
was represented with 42 % [5].
Commercial poultry and free-living birds are natural 
reservoirs of thermophilic campylobacters. The organism 
has been isolated from numerous bird species, including 
Columbiformes and domestic and free-living Galliformes 
and Anseriformes. C. jejuni has been found in all areas of 
commercial poultry production [6, 7]. Prevalence rates in 
poultry, especially in slaughter-age broiler flocks, could 
reach 100 % on some farms. Although, Campylobacter is 
insignificant for poultry health, it is a predominant cause 
of foodborne gastroenteritis in humans worldwide, and 
contaminated poultry meat is recognized as the main 
source of human infections [7, 8]. In general, the knowl-
edge about Campylobacter in Kenya is limited. Most of 
the published reports describe prevalence and antibiotic 
resistance in Campylobacter of human origin [4, 9–11]. 
Other reports gave information about Campylobacter 
as cause of foodborne diseases [12] and contamination 
of raw chicken and beef from butcheries and markets in 
Nairobi [13]. Information on thermophilic Campylobac-
ter of animal origin from Kenya is lacking.
Resistance against antibiotics in bacteria is of public 
health concern. Most commonly used drugs in treatment 
of campylobacteriosis in humans are erythromycin, fluo-
roquinolones or tetracycline [14]. Although, this antimi-
crobial treatment is usually not necessary, however the 
misuse of antibiotics is widespread in Kenya [5]. Atten-
tion on resistance of Campylobacter is raising and warn-
ing has been launched not to misuse antibiotics such as 
macrolides, fluoroquinolones or alternative drugs [15]. 
Kenyan Campylobacter isolates from humans showed a 
high resistance rate against erythromycin (52 %), but only 
low resistance to ciprofloxacin, tetracycline and nalidixic 
acid with 6, 18 and 26 % in the past, respectively [5].
Clinical breakpoints of Campylobacter susceptibility 
based on epidemiological cut-off (ECOFF) values were 
recommended. EUCAST MIC distributions incorporate 
human and veterinary clinical data from several sources 
worldwide [16]. The method of choice for testing anti-
biotic susceptibility and determination of minimum 
inhibitory concentration (MIC) values of Campylobacter 
isolates is the broth microdilution assay [17, 18].
In addition to phenotypical determination of antibiotic 
resistance, genetic analysis of resistance determinants 
in Campylobacter can be carried out. A replacement of 
threonine by isoleucine at amino acid 86 in the gyrA gene 
[19, 20] and a mutation at position 2074 and 2075 on the 
23S rRNA gene are the main mechanisms for fluoroqui-
nolone and erythromycin resistance, respectively [21]. 
Presence of tet(O) and/or tet(A) genes is responsible for 
tetracycline resistance [22]. A mismatch amplification 
mutation assay (MAMA–PCR) can be used for detection 
of the mutations in gyrA and 23S rRNA genes in C. coli 
and C. jejuni responsible for ciprofloxacin and erythro-
mycin resistance, respectively [21, 23]. PCR-restriction 
fragment length polymorphism (PCR–RFLP) technique 
[24] is available for detection of erythromycin resistance 
as well as specific PCR assays for tet(O) and tet(A) genes. 
These methods allow the investigation of antibiotic 
resistance of Campylobacter even in samples from which 
no Campylobacter could be isolated.
To the best of our knowledge there is no report availa-
ble about antibiotic resistance of thermophilic Campylo-
bacter species isolated from chicken in Kenya. MICs and 
results of molecular assays on the resistance of recent 
Kenyan C. coli and C. jejuni are presented.
Methods
Sample collection and Campylobacter isolation
In total, 35 geographically different native breed layer 
flocks were sampled. The chickens were housed in back-
yards and homesteads of small scale farmers from the 
outskirts of Thika, a town 40 km northeastern of Nairobi, 
Kenya. Farmers kept between 10 and 1000 layers. The 
birds were fed on commercially formulated ration from 
different sources and sometimes supplied with the lefto-
ver and residual food. All the manufactures used anti-
biotics as part of the ingredients in the feed. During the 
rearing of these chickens, antibiotics were used for pre-
vention and treatment of diseases without any instruc-
tions. Ten to 30 cloacal swabs and faecal samples were 
collected from each flock according to flock size. Campy-
lobacter were isolated in Kenya Medical Research Insti-
tute, Nairobi according to the guidelines of ISO 10272-1 
[25]. The isolates were preserved in 1.5  ml Eppendorf 
tubes filled with skimmed milk medium for 1-week 
transportation from Kenya to Friedrich–Loeffler-Institut, 
Jena, Germany for further laboratory analysis. Campylo-
bacter strains were re-cultivated on both Mueller–Hin-
ton agar and CCDA (Oxoid GmbH, Wesel, Germany) 
under microaerophilic conditions (5 % O2, 10 % CO2, and 
85 % N2) at 37 °C for 48–72 h.
DNA extraction
DNA from viable bacteria was extracted using the High 
Pure PCR Template Preparation Kit™ (Roche Diag-
nostics, Mannheim, Germany) according to the man-
ufacturer’s instructions. Skimmed milk samples of 
Campylobacter that could not be re-cultivated were 
treated with phenol–chloroform to extract DNA. Briefly, 
500  µl of skimmed milk medium was boiled for 5  min. 
After cooling the liquid was mixed with 500 µl buffer-sat-
urated phenol (Carl Roth GmbH, Karlsruhe, Germany) 
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and centrifuged for 5  min. at 13,400  rpm (miniSpin, 
Eppendorf, Hamburg, Germany). 500  µl chloroform/
isoamyl alcohol (24:1 vol/vol) was added to the aqueous 
phase, mixed and centrifuged for 5  min. at 13,400  rpm. 
DNA from the aqueous phase was precipitated by mix-
ing with 0.6 volume of isopropanol at room tempera-
ture. After centrifugation, the supernatant was discarded 
and the DNA was air dried and finally dissolved in 50 µl 
10 mM Tris (Carl Roth GmbH).
Multiplex PCR for identification of Campylobacter species
A mPCR assay was used to identify thermophilic 
Campylobacter species (C. jejuni, C. coli, and C. lari) as 
described by El-Adawy et  al. [26]. Briefly, the PCR was 
performed in a 50-μl reaction mixture containing 5.0 μl 
of 10  ×  Taq reaction buffer complete (Jena Bioscience 
GmbH, Jena, Germany), 2.0  μl of dNTP mix (2  mM 
each; Carl Roth GmbH), 2.0  μl of each primer (Jena 
Bioscience GmbH), and 0.2  μl of Taq Pol thermostable 
DNA polymerase (Jena Bioscience GmbH). Amplifica-
tion reactions were carried out in a TRIO Thermoblock 
cycler (Biometra, Göttingen, Germany) using the fol-
lowing programme: one cycle of 1  min at 96  °C was 
followed by 35 cycles each consisting of 60  s at 95  °C 
of denaturation, 90  s at 59  °C of annealing, and 60  s at 
72 °C of elongation. The PCR was terminated after a final 
extension step of 5  min. at 72  °C. Amplification gener-
ated 857, 589, 522, and 462 base pair DNA fragments 
specific for the genus Campylobacter and the species C. 
jejuni, C. lari, and C. coli, respectively. For analysis, 20 μl 
of PCR products were subjected to electrophoresis in a 
1.5 % agarose gel for 1 h, stained with ethidium bromide 
(0.5 μg/ml), and visualized under UV light. Results were 
documented using BioImage system GeneGenius (Syn-
gene, Synoptics Ltd., Cambridge, UK). Reference strains 
C. jejuni DSM 4688, C. coli DSM 4689, and C. lari DSM 
11375 (Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH, Braunschweig, Germany) were used 
as positive controls.
Antimicrobial susceptibility testing and determination 
of MICs
The antimicrobial susceptibility of C. jejuni and C. coli 
isolates was tested against seven antibiotic agents (chlo-
ramphenicol, erythromycin, ciprofloxacin, nalidixic 
acid, gentamicin, streptomycin, and tetracycline) using 
the Sensititre™ Campylobacter plates—EUCAMP (Trek 
Diagnostic Systems Ltd., East Grinstead, UK). The MIC 
values were detected using different concentration ranges 
as previously described [23]. Briefly, Campylobacter iso-
lates grown on Mueller–Hinton agar (Oxoid GmbH) 
supplemented with 10  % bovine blood under micro-
aerophilic conditions were suspended in NaCl solution 
(0.9  %) to obtain a turbidity corresponding to a McFar-
land standard of 0.5 (Dr. Lange, CADAS photometer 
30, Berlin, Germany). One-hundred and fifty milliliters 
of the above suspension were diluted with 10  ml Muel-
ler–Hinton broth (Oxoid GmbH) resulting in a concen-
tration of approximately 106–107 colony forming units 
(cfu)/ml. One hundred milliliters of the inoculum was 
filled in each well of the plate; the plates were sealed 
and incubated at 37  °C for 24  h under microaerophilic 
conditions. Results were read either visually or pho-
tometrically (Tecan Deutschland GmbH, Crailsheim, 
Germany) using the computer program easyWIN fit-
ting (version V6.1, 2000). C. jejuni DSM 4688 and C. coli 
DSM 4689 (Deutsche Sammlung von Mikroorganismen 
und Zellkulturen GmbH) were included in each batch of 
broth microdilution assay for quality control. The lowest 
concentration of antibiotics that prevents visible growth 
of the microorganism is defined as the MIC.
Molecular biological detection of antibiotic resistance 
determinants
Extracted Campylobacter DNA from all samples and 
strains was used for molecular biological determination 
of selected antibiotic resistance determinants by PCR.
Erythromycin resistance
Detection of mutations at positions 2074 and 2075 in 
domain V of the 23S rRNA gene, which mediates resist-
ance to erythromycin, was carried out by MAMA–PCR 
and PCR–RFLP as described previously [21, 24]. Genes 
responsible for resistance of erythromycin and cipro-
floxacin were tested at two loci using MAMA–PCR and 
PCR–RFLP. Primers and their sequences are given in 
Table 1.
Ciprofloxacin resistance
A single point mutation (Thr-86-Ile) in the quinolone 
resistance-determining region (QRDR) of gyrA gene 
was defined as source of high-level resistance to fluoro-
quinolones [23]. MAMA–PCR for C. jejuni isolates was 
carried out as described previously [27], for C. coli a pro-
cedure according to Zirnstein et al. [28] was used. Primer 
details are given in Table 1.
Tetracycline resistance
Primers DMT1 and DMT2 (Jena Bioscience GmbH) were 
used for the detection of the tet(O) gene which is strongly 
associated with tetracycline resistance in C. jejuni and C. 
coli as described previously [29]. As a second gene locus 
associated with tetracycline resistance the presence of 
tet(A) was examined by a previously described PCR assay 
[22]. An alternative, in-house validated PCR assay was 
created based on tet(A) sequences (GenBank acc. no. 
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JX891463 and JX891464)). Briefly, primers tet-A-1 and 
tet-A-2 (Table 1; Jena Bioscience GmbH) were used with 
the following PCR programme: An initial denaturation at 
96 °C for 60 s was followed by 35 cycles of denaturation 
(96 °C for 15 s), annealing (49 °C for 60 s) and extension 
(72 °C for 30 s). PCR was terminated by final extension at 
72 °C for 60 s. The PCR resulted in a 486 bp product.
All PCR products were analyzed by electrophoresis on 
1.5  % agarose gels, staining with ethidium bromide and 
visualization under UV light.
DNA sequencing
PCR products obtained by tet(A) PCRs were sequenced 
by cycle sequencing with BigDye Terminator v1.1 Cycle 
Sequencing Kit (Applied Biosystems, Darmstadt, Ger-
many) according to the instructions of the manufacturer. 
In addition to the amplification primers of the Tet(A)-F/R 
fragment tet-A-A (5’-AAT TTT CTT CAA ATA AGG-3’) 
and tet-A-B (5’-GTC ATT CTT ATA TTA AGT GG-3’) 
were used as sequencing primers. Sequencing products 
were analyzed with an ABI PRISM 3130 genetic analyzer.
MALDI‑TOF mass spectrometry
Cultured bacteria were suspended in 300  µl of bi-dis-
tilled water and mixed with 900 ml of ethanol (Carl Roth 
GmbH). Further treatment of samples and measurement 
were described by El-Ashker et al. [30].
Results
Identification of bacteria
In total, 58 isolates suspected as Campylobacter were 
recovered from faeces and cloacal swabs of chicken flocks 
in Kenya. After storage in skimmed milk medium and 
transportation to Germany only 40 of these isolates could 
be re-cultivated. Four C. coli and 31 C. jejuni were identi-
fied by mPCR (Table 2). Five other isolates were identi-
fied by MALDI-TOF mass spectrometry as members of 
genera Bacillus, Staphylococcus, Ochrobactrum as well as 
two Bordetella isolates.
Eighteen skimmed milk tubes contained Campylobac-
ter DNA [14 C. coli, 3 C. jejuni and one sample harboured 
both C. coli and C. jejuni (Table 2)].
Antimicrobial susceptibility profiles and multidrug 
resistance
The results of antimicrobial susceptibility testing of C. 
jejuni and C. coli isolates and the rate of resistance to 
seven antimicrobial agents are given in Tables  3 and 4, 
respectively. The C. jejuni isolates showed a high rate of 
resistance to nalidixic acid, tetracycline and ciprofloxacin 
with 77.4, 71.0 and 71.0  %, respectively. Low resistance 
rates were detected for gentamicin and chloramphenicol, 
both with 25.8 % of the isolates. For the low number of C. 
coli isolates (n = 4) a similar pattern was observed. Only 
two isolates were susceptible to all tested antimicrobial 
agents, one isolate was resistant to all tested antibiotics.
The multidrug resistance profiles of 31 C. jejuni isolates 
are shown in Table  5. Multidrug resistance to three or 
more classes of antibiotics was found in 19 isolates (61.3 %) 
and was observed in a range between 5.3 and 26.3 %.
Molecular biological detection of antibiotic resistance 
determinants
DNA of 35 viable Campylobacter isolates and of 18 non-
growing samples was investigated by PCR to detect anti-
biotic resistance. Mismatch amplification mutation assay 
Table 1 List of primers and primer sequences used for detection of antimicrobial resistance genes
a 23S rRNA gene mutation
b gyrA gene mutation Campylobacter jejuni
c gyrA gene mutation Campylobacter coli




TTA GCT AAT GTT GCC CGT ACC G
TAG TAA AGG TCC ACG GGG TCG C




AAT TGA TGG GGT TAG CAT TAG C




TTT TTA GCA AAG ATT CTG AT




TAT GAG CGA TAT TAT CGG TC
TAA GGC ATC GTA AAC AGC CA
192 [24]
Tetracycline tet(O) PCR DMT 1
DMT 2
GGC GTT TTG TTT ATG TGC G




GTG AAA CCC AAC ATA CCC C




GCT CAC GTT GAC GCA GGA AAG
ATC GTC ATT GTC CGT TAC
486 This study
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(MAMA–PCR) was used to characterize a gyrA gene 
mutation associated with ciprofloxacin resistance as well 
as mutations in 23S rRNA genes as cause of erythromycin 
resistance. The molecular biological detection of resist-
ance to ciprofloxacin in both C. coli and C. jejuni was also 
confirmed by change of amino acid 86 from threonine to 
isoleucine in the gyrA gene. Additional to the ciprofloxa-
cin resistant Campylobacter isolates (Tables  3, 4), three 
Campylobacter DNAs were detected harbouring the gyrA 
gene mutation. The results were confirmed by PCR–RFLP 
according to Vacher et  al. [24]. Mutations at positions 
2074 and 2075 of the 23S rRNA genes in 13 phenotypi-
cally erythromycin-resistant isolates could neither be 
detected by using PCR–RFLP nor MAMA–PCR.
The tet(O) gene which is mainly responsible for tetra-
cycline-resistance was detected by PCR in 12 out of 22 
resistant C. jejuni isolates (54.5 %) and in all tetracycline 
resistant C. coli isolates. tet(O) gene was not detected in 
DNA extracted from the non-growing samples. Addi-
tionally, a newly developed PCR assay was used for the 
detection of the tet(A) gene. tet(A) was detected in 28 
out of 31 C. jejuni (90.3 %) and in all 4 C. coli isolates. 
In 3 out of 14 non-growing samples which harboured 
C. coli DNA, tet(A) gene could be found as well as in 
the one sample where both C. jejuni and C. coli were 
detected.
Table 2 Results of  cultivation and  multiplex PCR identifi-
cation of Campylobacter isolates
Cultivation mPCR identification of Campylobacter Total
n (%)




Positive (n) 31 4 5 0 40 (69.0)
Negative (n) 3 14 0 1 18 (31.0)
Table 3 Results of MIC determination and resistance rates of Kenyan Campylobacter jejuni isolates
Class Antibiotic 
(µg/ml)




0.06 0.12 0.25 0.5 1 2 4 8 16 32 64
Macrolides
Chloramphenicol 9 3 6 5 8 25.8
Erythromycin 14 1 2 2 12 51.6
Fluoroquinolones Ciprofloxacin 5 2 2 2 1 19 71.0
Quinolones Nalidixic acid 4 1 2 2 22 77.4
Aminoglycosides
Gentamicin 2 1 4 11 5 2 1 5 25.8
Streptomycin 12 2 4 1 12 41.9
Tetracyclines Tetracycline 6 1 2 1 1 20 71.0
Boldface in italic type indicates the number of resistant isolates. A thick black line indicates the break point between clinically sensitive and resistant strains
R* resistance rate
Table 4 Results of MIC determination and resistance rates of Kenyan Campylobacter coli isolates
Class Antibiotic 
(µg/ml)




0.06 0.12 0.25 0.5 1 2 4 8 16 32 64
Macrolides
Chloramphenicol 2 2 50.0
Erythromycin 4 0
Fluoroquinolones Ciprofloxacin 1 3 75.0
Quinolones Nalidixic acid 1 3 75.0
Aminoglycosides
Gentamicin 1 1 1 1 25.0
Streptomycin 2 2 0
Tetracyclines Tetracycline 1 1 1 1 25.0
Boldface in italic type indicates the number of resistant isolates. A thick black line indicates the break point between clinically sensitive and resistant strains
R* resistance rate
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Discussion
The antimicrobial susceptibility patterns among Campy-
lobacter isolates originating from chicken in Kenya were 
analyzed according to the guidelines of CLSI for Enterobac-
teriaceae which had been guided by previous reports [17, 
31–34]. Clinical breakpoints for interpretation of MIC val-
ues of C. jejuni and C. coli from chicken are available [31, 
35]. In this study a commercially available broth microdilu-
tion assay was used for the determination of MIC values for 
seven antibiotics. The assay already proved to be suitable in 
previous investigations [21, 27, 34, 36, 37].
In this study, only 40 out of 58 suspected Campylobac-
ter samples could be re-cultivated. The storage condi-
tions (temperature, microaerophilic atmosphere) using 
skimmed milk medium were possibly not ideal. However, 
it had been demonstrated that C. jejuni can survive up to 
14 days at 1 °C or 2.5 days at 20 °C in sterile skimmed milk 
[38, 39]. Alternative storage of Campylobacter cultures 
using transport medium (for example Amies medium) or 
cryovials is recommended for future investigations.
In 53 out of 58 collected samples, Campylobacter DNA 
was identified by mPCR assay [26]. The majority of the 
cultures proved to be C. jejuni (88.6 %) which is in agree-
ment with previous studies in chicken [6, 7]. In 18 DNA 
extracts of non-viable samples, 3 C. jejuni (16.7 %), one 
mixed population of C. jejuni/C. coli and 14 C. coli were 
identified. These findings are in agreement with those of 
a previous study that found a longer viability of C. jejuni 
in comparison to C. coli in biological milieu [40]. It may 
be possible that some C. coli isolates had been lost dur-
ing the shipment period. In summary, C. jejuni was iden-
tified much more often than C. coli (64.2  %) by mPCR 
investigation. In agreement with other studies, the find-
ings highlighted the usefulness of mPCR as a reliable, 
sensitive, time and cost saving method for identification 
of thermophilic Campylobacter [26].
The antibiotic susceptibility of 35 Campylobacter iso-
lates from Kenyan chicken was investigated using Euro-
pean Committee on Antimicrobial Susceptibility Testing 
and epidemiological cut-off values (EUCAST–ECOFFS) 
[16]. A broth microdilution assay was used as a standard-
ized, easy, and reliable method for the determination of 
MIC of seven antibiotics [17, 31–34]. High resistance rates 
were obtained for ciprofloxacin, nalidixic acid and tetracy-
cline with more than 70  % which is in agreement with a 
recent European Food Safety Authority (EFSA) report [41]. 
These results are in contrast to those of Brooks et  al. [5] 
who reported resistance rates for Campylobacter recov-
ered from humans with diarrhoea in Western Kenya for 
ciprofloxacin, nalidixic acid and tetracycline with 6, 26 and 
18 % in 2006, respectively. The general high rates of resist-
ance in the chicken isolates may be caused by availability 
and uncontrolled use of antibiotics by small farmers [42].
Resistance to chloramphenicol is remarkable with 
25.8  % in this investigation. Use of chloramphenicol 
is banned in animal breeding in Europe for more than 
20  years, but still it is often used in many third world 
countries [43]. It is easy to obtain antibiotics over-the-
counter and other unregulated venues and injudicious 
use promotes the development of resistance to antimi-
crobial agents. Resistance to gentamicin in the isolates 
obtained from chicken was low in this study (25.8 %), but 
Campylobacter isolated from broilers and turkeys were 
totally susceptible to gentamicin [37, 41, 44, 45]. Erythro-
mycin resistance rates found in this study correspond to 
those of similar studies elsewhere [41, 44, 45].
Multidrug resistance was detected in 61.3  % of the 
Campylobacter isolates. Eleven different combinations 
were found (Table 5). Frequent, resistance to ciprofloxa-
cin, nalidixic acid and tetracycline was identified (17 out 
of 19 multidrug resistant isolates) which is in agreement 
with previous investigation using Vietnamese Campy-
lobacter isolates [45]. However, EFSA [41] reported low 
level of multidrug resistance in C. jejuni from broilers of 
the member states of the EU.
The emerging of antibiotic resistance has been attrib-
uted to the overuse and misuse of antimicrobial agents 
in both the developed and developing world. Antibiotics 
are widely used as growth supplements in livestock and 
to prevent infections [46]. The emerging of multidrug 
resistance may reflect acquisition of different resistance 
determinants on the same DNA molecule or single deter-
minants, such as multidrug pumps, that specify efflux 
activity against different antimicrobial agents [47]. The 
mechanisms of genetic resistance might be chromosomal 
or plasmid-borne, and represent a combination of endog-
enous and acquired genes. In general, mechanisms of 
Table 5 Multidrug resistance profiles of 19 Campylobacter 
jejuni isolates
TET tetracycline, CIP ciprofloxacin, NAL nalidixic acid, ERY erythromycin, GEN 
gentamicin, STR streptomycin, CHL chloramphenicol
Antibiotic resistance profile No. of resistant 
isolates (%)
TET, CIP, NAL, ERY, GEN, STR, CHL 1 (5.3)
TET, CIP, NAL, ERY, STR, CHL 1 (5.3)
TET, CIP, NAL, ERY, GEN, STR 3 (15.8)
TET, CIP, NAL, GEN, STR, CHL 1 (5.3)
TET, CIP, NAL, ERY, STR 2 (10.5)
TET, CIP, NAL, ERY, CHL 1 (5.3)
TET, CIP, NAL, ERY 2 (10.5)
TET, CIP, NAL, STR 1 (5.3)
TET, CIP, NAL 5 (26.3)
CIP, NAL, ERY, STR, CHL 1 (5.3)
CIP, NAL, STR 1 (5.3)
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antibiotic resistance as modification of the antibiotic by 
aminoglycoside-modifying enzymes (AphA, AadE, Sat), 
enzymatic inactivation of the antibiotic by β-lactamase 
and modification of the DNA gyrase target, mutations 
in 23S rRNA genes were included for aminoglycosides, 
beta-lactams, fluoroquinolones, macrolides and tetracy-
clines, respectively [48, 49]. The multidrug efflux pump 
CmeABC has been involved in the resistance mecha-
nisms of C. jejuni and C. coli to tetracyclines, fluoroqui-
nolones, macrolides and beta-lactams [49].
Molecular biological methods were used for detection 
of antibiotic resistance determinants either using DNA 
isolated from cultures or that of non-cultured bacteria 
[27, 37]. All isolates of this study which were resistant to 
ciprofloxacin carried a mutation of the amino acid 86 of 
the gyrA resulting in a change from threonine to isole-
ucine. This mutation was detected also in 3 DNA sam-
ples extracted from skimmed milk. The MAMA–PCR 
protocol allowed the detection of the gyrA mutation and 
PCR–RFLP was confirming the mutation from (ACA to 
ATA) of amino acid 86. This result was in agreement with 
previous reports showing that both methods are simple, 
reliable, rapid tools that can be used as screening meth-
ods [27, 37]. In Campylobacter, resistance to erythro-
mycin is chromosomally encoded by an alteration of the 
23S rRNA gene. High level resistance to erythromycin is 
caused by mutations at position 2074 and/or 2075 of the 
domain V of this gene. In this study the mutations were 
neither detected by MAMA–PCR nor by PCR–RFLP.
The tet(O) gene is known to be responsible for tetra-
cycline resistance in Campylobacter isolates [29]. In this 
study, only 54.5  % of the tetracycline resistant isolates 
harboured the tet(O) gene. The tet(A) gene also plays role 
in resistance to tetracycline [22]. The efflux gene tet(A) 
is coding for an approximately 46 kDa membrane-bound 
efflux protein for membrane-associated proteins and is 
involved in the export of tetracycline from the cell [50]. 
In this study, using the recommended primers for tet(A) 
amplification [18] PCR products of 696  bp instead of 
888 bp were obtained. DNA sequencing of amplicons and 
database search resulted in 99.0 % homology to a partial 
putative integral membrane protein and a putative peri-
plasmic protein. Hence, a new PCR assay based on tet(A) 
gene sequences for C. jejuni (acc. no. JX891464) and 
C. coli (acc. no. JX891463) was developed. Parameters 
such as limit of detection, limit of quantification, PCR 
efficiency and specificity were considered during an in-
house validation process. Amplicon length was 486 and 
the amplicons were sequenced to confirm the identity. 
The tet(A) gene was much more frequently identified in 
the Kenyan Campylobacter isolates than tet(O) (35 vs 13).
To the best of our knowledge this is the first report 
on the status of antibiotic susceptibility of thermophilic 
Campylobacter from chicken in Kenya. High level of 
resistance to ciprofloxacin, erythromycin and nalidixic 
acid as well as multidrug resistance was detected previ-
ously in Kenya. In Kenya, this problem is reported to be 
caused by the increasing rate of unregulated over-the-
counter sale without prescriptions of these antibiotics, 
mainly to humans self-treatment of suspected infections 
and to a lesser extent for use in animals [51]. These find-
ings also demonstrate the potential for antibiotic-resistant 
bacteria to spread through the food chain from animals 
treated with antibiotics for humans. Such misuse and 
overuse may have resulted in the selection of resistant 
mutants or acquisition of antibiotic resistance genes from 
other organisms through the process of genetic exchange.
It is recommendable that a long-term local surveillance 
programme is adopted for monitoring changes in resist-
ance among Campylobacter isolates. Efforts to establish 
at least a National Laboratory with facilities for perform-
ing phenotyping and genotyping methods is highly rec-
ommended. Emphasis should be given on educational 
advertising to reduce the input of antibiotics in animal 
breeding to minimize the potential hazard for humans.
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